Health care continues to be one of the top issues that voters want to hear candidates talk about during their 2018 congressional campaigns, according to the results of Kaiser Health’s June 2018 tracking poll.
Democrats reoriented their uphill push to block U.S. Senate confirmation of President Donald Trump’s nominee to the Supreme Court, moving healthcare to the center of their strategy and putting less emphasis on abortion rights.
The U.S. Justice Department announced charges against 601 people including doctors and nurses for taking part in healthcare fraud and opioid-related crimes that resulted in more than $2 billion in losses.
While many of us from blue states and urban bubbles fret over some of the actions of President Donald Trump, it’s good to take a clear-eyed view of whether or not Trump and this administration has been good for the medical marketing industries. Moreover, it’s useful to consider how a “blue wave” in the midterm elections might change the dynamic.
LevLane has been named an agency of record for the launch of a new wellness testing product from Genomind.
Chinese e-commerce giant Alibaba Group Holding Ltd. will inject some of its online pharmacy business into a listed unit in a deal valued at HK$10.6 billion ($1.35 billion), the firm said in a statement.
There are plenty of problems lurking on America’s career ladder, but here is a big one: the U.S. healthcare systems are designed for the workforce of 1950.
ISPOR, the professional society for health economics and outcomes research, announced that registration is open for a new webinar that reviews the, “Top 10 Trends in Health Economics and Outcomes Research.”
United States health spending is projected to rise 5.3 percent in 2018, reflecting rising prices of medical goods and services and higher Medicaid costs.
There is a fundamental disconnect between companies and consumers: Healthcare brands often fail to address patients’ emotional journeys.